Evidence map›Paper›PMID 20580423›Full record

Trial reportLancet (London, England)2010

Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial.

David R McCance, Valerie A Holmes, Michael J A Maresh, Christopher C Patterson, James D Walker, Donald W M Pearson, Ian S Young, Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Lancet (London, England), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 14 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 14 pooled it
16.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 14 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Efficacy of vitamin C supplementation during pregnancy in the prevention of preterm birth: a systematic review and meta-analysis.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Vitamin supplementation for preventing miscarriage.The Cochrane database of systematic reviews · 2016
    Pooled it
  10. Vitamin C supplementation in pregnancy.The Cochrane database of systematic reviews · 2015
    Pooled it
  11. Vitamin E supplementation in pregnancy.The Cochrane database of systematic reviews · 2015
    Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

David R McCanceRegional Centre for Endocrinology and Diabetes, Royal Victoria Hospital, Belfast, UK. david.mccance@belfasttrust.hscni.net
Valerie A Holmes
Michael J A Maresh
Christopher C Patterson
James D Walker
Donald W M Pearson
Ian S Young
Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group
Queen's University Belfast · GBAberdeen Royal Infirmary · GBRoyal Victoria Hospital · GBSt John's Hospital · GBSt Mary's Hospital · GB

Funding

Wellcome TrustWellcome Trust 067028/Z/02/ZWellcome Trust 083145/Z/07/ZWellcome Trust 210183
6 · The paper itself

Abstract

backgroundResults of several trials of antioxidant use during pregnancy have not shown a reduction in pre-eclampsia, but the effect in women with diabetes is unknown. We aimed to assess whether supplementation with vitamins C and E reduced incidence of pre-eclampsia in women with type 1 diabetes.

methodsWe enrolled women from 25 UK antenatal metabolic clinics in a multicentre randomised placebo-controlled trial. Eligibility criteria were type 1 diabetes preceding pregnancy, presentation between 8 weeks' and 22 weeks' gestation, singleton pregnancy, and age 16 years or older. Women were randomly allocated in a 1:1 ratio to receive 1000 mg vitamin C and 400 IU vitamin E (alpha-tocopherol) or matched placebo daily until delivery. The randomisation sequence was stratified by centre with balanced blocks of eight patients. All trial personnel and participants were masked to treatment allocation. The primary endpoint was pre-eclampsia, which we defined as gestational hypertension with proteinuria. Analysis was by modified intention to treat. This study is registered, ISRCTN27214045.

findingsBetween April, 2003, and June, 2008, 762 women were randomly allocated to treatment groups (379 vitamin supplementation, 383 placebo). The primary endpoint was assessed for 375 women allocated to receive vitamins, and 374 allocated to placebo. Rates of pre-eclampsia did not differ between vitamin (15%, n=57) and placebo (19%, 70) groups (risk ratio 0.81, 95% CI 0.59-1.12). No adverse maternal or neonatal outcomes were reported.

interpretationSupplementation with vitamins C and E did not reduce risk of pre-eclampsia in women with type 1 diabetes. However, the possibility that vitamin supplementation might be beneficial in women with a low antioxidant status at baseline needs further testing.

fundingThe Wellcome Trust.

Indexed as

AdultAntioxidantsAscorbic AcidDiabetes Mellitus, Type 1FemaleHumansOxidative StressPre-EclampsiaPregnancyVitamin EYoung AdultAntioxidantsAscorbic AcidVitamin E

Identifiers

PMID20580423
PMCPMC2911677
OpenAlexW2138881519

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.